Clinical Trials Logo
  1. Home
  2. Pulmonary Cancer
  3. NCT00344773

First-line Treatment for Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) Mutation

Pulmonary Cancer Clinical Trial

Official title:
An Open-label, Multi-centre Study to Evaluate Efficacy and Safety of Gefitinib as the First-line Treatment for Locally Advanced (IIIB), Metastatic (IV) or Recurrent Pulmonary Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) Mutation.

Clinical Trial Summary

The purpose of this study is to evaluate the overall objective tumor response rate (ORR) of Gefitinib.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00344773
Study type Interventional
Source AstraZeneca
Contact
Status Completed
Phase Phase 2
Start date March 2006
Completion date December 2007
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03144622 - 18F-FSPG PET/CT Imaging in Patients With Cancers
Completed NCT01860898 - A Phase I Study of iPS Cell Generation From Patients With COPD N/A
Completed NCT02476526 - Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease Phase 4
Completed NCT00098085 - Study of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung Cancer Phase 2
Completed NCT05011890 - Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare® N/A
Completed NCT02616211 - An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors
Completed NCT03293433 - Quantification of microRNAs in Diagnosis of Pulmonary Nodules
Recruiting NCT05545085 - Thoracoscopic Laser Speckle Contrast Imaging for Segment Resections
Enrolling by invitation NCT06102369 - The Role of Narrow Band Imaging (NBI) Bronchoscopy in Detecting Bronchial Squamous Dysplasia in Lung Cancer
Not yet recruiting NCT05781581 - A Retrospective Cohort Study for Main Postoperative Complications After SARS-CoV-2 Infection
Terminated NCT02673021 - MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s) N/A
Not yet recruiting NCT05857995 - Precision Lung Cancer Survivorship Care Intervention N/A
Recruiting NCT05521789 - Erector Spinae Block for Thoracic Surgery Phase 4
Recruiting NCT04699188 - Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation Phase 1/Phase 2
Completed NCT01048762 - Multidisciplinary Rehabilitation After Cancer Pulmonis Operation Phase 2
Recruiting NCT05977803 - Contribution of the CEST Sequence in the Characterization of Radionecrosis of Brain Metastases of Pulmonary Origin N/A
Not yet recruiting NCT05694949 - Main Postoperative Complications After COVID-19
Completed NCT05915221 - Effect of SMS Use on Postoperative Respiratory and Cough Exercise Compliance N/A
Active, not recruiting NCT04740047 - Cios Mobile 3D Spin for Robotic Bronchoscopy
Completed NCT02410603 - Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer